MedTrace Logo

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

NCT00294502 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-02-22

No results posted yet for this study

Summary

To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.

Conditions

  • ESRD

Interventions

DRUG

Gentamycin/citrate, Minocycline/EDTA

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Antanole Bearabe, MD · Henry Ford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Completion
2004-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00294502 on ClinicalTrials.gov